{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Lund AW"],"funding":["American Cancer Society","NCI NIH HHS","NIH NCI"],"pagination":["1996-1998"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9106852"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["28(10)"],"pubmed_abstract":["An unbiased approach to map the sentinel lymph node landscape reveals progressive immune dysfunction associated with micrometastasis in patients with stage I-III cutaneous melanoma. Evidence of tumor-induced lymph node dysfunction may motivate new hypotheses for neoadjuvant therapy with potential to reinvigorate endogenous antitumor immunity. See related article by Yaddanapudi et al., p. 2069."],"journal":["Clinical cancer research : an official journal of the American Association for Cancer Research"],"pubmed_title":["Standing Watch: Immune Activation and Failure in Melanoma Sentinel Lymph Nodes."],"pmcid":["PMC9106852"],"funding_grant_id":["R01 CA238163","RSG-18–169–01"],"pubmed_authors":["Lund AW"],"additional_accession":[]},"is_claimable":false,"name":"Standing Watch: Immune Activation and Failure in Melanoma Sentinel Lymph Nodes.","description":"An unbiased approach to map the sentinel lymph node landscape reveals progressive immune dysfunction associated with micrometastasis in patients with stage I-III cutaneous melanoma. Evidence of tumor-induced lymph node dysfunction may motivate new hypotheses for neoadjuvant therapy with potential to reinvigorate endogenous antitumor immunity. See related article by Yaddanapudi et al., p. 2069.","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 May","modification":"2024-12-04T03:10:01.442Z","creation":"2024-12-04T03:10:01.442Z"},"accession":"S-EPMC9106852","cross_references":{"pubmed":["35262676"],"doi":["10.1158/1078-0432.CCR-22-0214","10.1158/1078-0432.ccr-22-0214"]}}